How Does Ketamine Therapy Work? A Complete Guide

What Is Ketamine Therapy?

Ketamine therapy is the supervised use of sub-anesthetic doses of ketamine to treat mental health conditions such as depression, anxiety, and PTSD. Ketamine itself is a dissociative anesthetic that has been FDA-approved for surgical and procedural anesthesia since 1970.

The medication has also appeared on the World Health Organization's List of Essential Medicines since 1985.⁷

When used for mental health, ketamine is prescribed off-label. Off-label prescribing is a widespread, legally accepted practice across psychiatry and other specialties where a provider prescribes an FDA-approved medication for a use beyond its original indication.⁹

Rather than a single medication event, ketamine therapy is delivered as part of a managed care program that includes evaluation, guided dosing sessions, and integration support.

Decades of clinical use and a substantial body of peer-reviewed research support ketamine therapy as an established therapeutic approach. A licensed provider determines whether it is appropriate for each individual based on a thorough evaluation.

Key terms to understand include:

• Racemic ketamine: The original molecule, prescribed off-label for mental health conditions via intravenous (IV), sublingual, or subcutaneous routes.
• Esketamine (Spravato): An FDA-approved nasal spray derived from one half of the ketamine molecule, administered in certified healthcare settings under Risk Evaluation and Mitigation Strategy (REMS) protocols.
• Off-label prescribing: A common, legal practice in psychiatry where a physician prescribes an FDA-approved medication for a use beyond its original approved indication.

How Does Ketamine Therapy Work in the Brain?

Unlike most traditional psychiatric medications that modulate serotonin or norepinephrine, ketamine acts on the glutamate system. Glutamate is the brain's most abundant excitatory neurotransmitter.

Working through glutamate produces rapid changes in neural connectivity rather than relying on gradual receptor adaptation.

What Do NMDA Receptors Have to Do with Ketamine?

NMDA (N-methyl-D-aspartate) receptors are proteins on nerve cells that regulate communication between neurons. They play a central role in learning, memory, and mood regulation.

At sub-anesthetic therapeutic doses, ketamine temporarily modulates NMDA receptor activity, particularly on a specific subset of inhibitory interneurons. Modulating these receptors reduces a tonic inhibitory signal, which disinhibits downstream excitatory neurons and results in a controlled burst of glutamate release.

Because it works through NMDA pathways, ketamine functions fundamentally differently from how SSRIs or SNRIs work. The NMDA-mediated mechanism allows ketamine to initiate rapid neurobiological changes within hours, rather than the weeks typically associated with conventional antidepressants.

What Happens to Glutamate and AMPA Signaling after Ketamine?

Once NMDA receptor modulation triggers a glutamate surge, the excess glutamate activates a second type of receptor called AMPA receptors on postsynaptic neurons.

AMPA receptor activation initiates an intracellular signaling cascade that increases the production of brain-derived neurotrophic factor (BDNF). BDNF functions as a growth signal for neurons, sometimes described in research literature as "fertilizer" for brain cells.

Releasing BDNF activates the mTOR pathway, which stimulates the production of synaptic proteins needed to form new neural connections. The glutamate-AMPA-BDNF pathway acts on the neural architecture itself, not just neurotransmitter availability.

What Does Neuroplasticity Mean after a Ketamine Session?

Neuroplasticity refers to the brain's ability to form new neural connections and reorganize existing ones. In the context of ketamine therapy, the specific form of neuroplasticity involved is synaptogenesis, which is the growth of new synaptic connections between neurons.

Foundational research from Ronald Duman's lab at Yale demonstrated that a single sub-anesthetic dose of ketamine can restore synaptic connections lost due to chronic stress exposure.⁴ The research, published in Science (2010), showed measurable increases in dendritic spine density and synaptic function within 24 hours.

Chronic stress and depression are associated with synaptic atrophy, or a loss of connections, particularly in the prefrontal cortex. Ketamine's promotion of synaptogenesis helps reverse that structural deficit.

Biological openness creates what specialists sometimes call a "neuroplastic window," a period of heightened capacity for forming new thought patterns. The neuroplastic window is why integration practices like reflection and coaching after a session can be particularly effective for lasting cognitive change.

Why Can Ketamine Feel Faster than Traditional Antidepressants?

Traditional antidepressants like SSRIs and SNRIs work by gradually adjusting serotonin or norepinephrine levels at the synapse. Adjusting these levels requires weeks of consistent use before receptor adaptation produces noticeable symptom changes, typically taking four to eight weeks.

Ketamine bypasses the slow adaptation process entirely. Instead of waiting for receptor sensitivity to shift over weeks, ketamine triggers the glutamate-AMPA-BDNF cascade within hours.

Many people report noticeable symptom improvement within hours or days of their first session. Rapid onset is one of the most significant aspects of ketamine therapy, particularly for individuals experiencing acute distress or suicidal ideation.

The speed difference is not about potency, but rather about acting on a fundamentally different neurotransmitter system to produce structural neural changes.

What Can Ketamine Therapy Help Treat?

Providers prescribe ketamine for adults experiencing depression, anxiety disorders, and PTSD. It is also being studied and used in therapeutic contexts for related conditions including OCD, chronic pain, grief, burnout, and habit change.

The primary indications supported by evidence include:

• Depression: The most extensively studied indication, with a substantial body of peer-reviewed literature supporting ketamine's efficacy for both major depressive disorder and treatment-resistant depression.
• Anxiety disorders: Published data supports ketamine's anxiolytic effects, addressing both anxiety and frequently comorbid depression through its neuroplasticity-promoting mechanism.
• PTSD: Peer-reviewed studies report meaningful symptom reduction in post-traumatic stress disorder, with evidence strength varying by study design and treatment setting.
• Additional areas: Evidence is expanding across OCD, chronic pain, and behavioral health contexts, with varying levels of evidence strength by indication.

Adults experiencing these conditions can consider ketamine as an evidence-based option, not exclusively a last-resort treatment.

What Happens in a Ketamine Therapy Program?

Rather than a one-time medication event, a full ketamine program unfolds across medical evaluation, preparation, dosing, and integration. The program arc typically includes evaluation, preparation, the dosing session itself, and integration afterward.

What Happens before a Ketamine Session?

The pre-session phase includes health screening, evaluation, and preparation for the session experience.

During the intake process, a provider reviews your medical history, current medications, psychiatric history, and treatment goals. Contraindications are assessed to ensure safety.

Preparation also includes guidance on "set and setting," which refers to your mindset and physical environment for the session.

Preparation is a core component of the program, not an optional add-on. You will receive fasting guidelines, arrange for a peer treatment monitor to be present, set up a comfortable space, and review exactly what to expect.

What Happens During a Ketamine Session?

During a ketamine session, the medication is administered at a sub-anesthetic, clinician-determined dose. The session typically lasts one to two hours depending on the route of administration.

Common administration routes include:

• IV infusion: Delivered via slow intravenous drip in a clinic or medical office setting, offering high bioavailability.
• Sublingual tablets: Held between the cheeks and gums, then spit out. Administered at home under medical supervision with a peer treatment monitor present.
• Intranasal esketamine (Spravato): FDA-approved nasal spray administered in a certified healthcare setting under REMS protocols.
• Subcutaneous injection: Administered via a small insulin needle, typically at home, offering faster absorption and more consistent bioavailability than tablets.

Most people describe a sense of deep relaxation, an altered perception of time, and a feeling of emotional distance from habitual thought patterns. Some experience visual or sensory changes.

Most people find the dissociative state therapeutically meaningful within a supervised setting, describing it as a valuable shift in perspective. If the experience feels unfamiliar, preparation materials and the peer treatment monitor can help navigate it.

The route of administration is determined by care context, patient preference, and treatment setting. Each route delivers the same core mechanism, differing primarily in bioavailability, onset speed, and care setting.

What Happens After a Ketamine Session?

The post-session period—from immediately after the session through the following days—encompasses both the return to baseline and the integration phase.

Effects typically subside within one to two hours after the session ends. The only universally consistent restriction is avoiding driving or operating machinery until after a full night of sleep.

Individual experiences vary regarding downtime. Some people prefer to keep their schedule clear, while others feel ready to transition back to their routine and non-driving activities later the same day.

Treat this window as a therapeutic component, not downtime. Integration practices like journaling, guided reflection, and coaching help you process insights while the brain's neuroplastic window is open.

How Long Can Ketamine Therapy Effects Last?

The duration of therapeutic effects varies by individual and depends on several factors. Variables include the number of sessions, the condition being treated, and whether integration practices are maintained.

Noticeable symptom improvement often emerges within hours or days of the first session. More durable and cumulative benefits typically develop over a series of sessions combined with integration practices.

Some individuals experience sustained improvement for weeks or months following a treatment course, while others may benefit from periodic maintenance sessions.

Durability is influenced by the interplay of biological response, the number of sessions, and engagement with integration. Treatment frequency is personalized based on individual needs and provider guidance to establish therapeutic momentum.

Are There Any Side Effects or Risks with Ketamine Therapy?

Like all medications, ketamine can produce side effects. Side effects are expected, non-serious reactions that may occur during or shortly after a ketamine session and typically resolve within hours. Adverse events—serious, unexpected medical events—are rare in supervised therapeutic settings.

The overall risk profile is well-characterized in published research across both in-clinic and at-home settings. Understanding what to expect helps individuals make informed decisions in consultation with their care team.

What Side Effects Are Most Common During Ketamine Therapy?

The most commonly reported side effects during ketamine therapy include dissociation, nausea, dizziness, elevated blood pressure, and fatigue.

When side effects occur, they may include:

• Dissociation: A feeling of detachment from one's usual sense of self or surroundings. Within a supervised setting, most people find the shift in perspective therapeutically meaningful.
• Nausea: Some people experience mild nausea during or shortly after the session. Fasting guidelines and anti-nausea measures can reduce the likelihood.
• Elevated blood pressure: Some people experience a temporary increase in blood pressure during the session because ketamine has sympathomimetic properties. Cardiovascular screening is part of the intake process to manage the temporary stimulation.
• Dizziness and fatigue: Feeling tired or dizzy may occur during the post-session transition and typically resolves within hours.

These effects most often occur during or shortly after dosing, are monitored during the session, and typically diminish as the acute pharmacologic effects wear off over the next several hours. Preparation, screening, and the presence of a peer treatment monitor are designed to manage them proactively.

What Health Conditions Can Make Ketamine Therapy Unsafe?

Certain medical and psychiatric conditions may make ketamine therapy inappropriate for some individuals. Providers carefully assess your health history during the intake screening.

Primary conditions evaluated include:

• Uncontrolled hypertension: Because ketamine can temporarily increase blood pressure, individuals with uncontrolled hypertension may not be appropriate candidates.
• Psychotic disorders: Active psychosis or a history of psychotic disorders like schizophrenia is typically a contraindication due to ketamine's dissociative properties.
• Active substance use disorders: Individuals with active, untreated substance use disorders require careful evaluation given ketamine's potential for misuse.
• Pregnancy: Ketamine is not recommended during pregnancy.

A physician evaluates the full picture of an individual's health to determine eligibility. The screening process is a safety feature of the care model, ensuring therapy is delivered only when appropriate.

Does Ketamine Have Abuse and Addiction Potential?

Ketamine is classified as a Schedule III controlled substance by the DEA, which means it has recognized medical use and a moderate potential for physical or psychological dependence.

In a ketamine context, dependence involves tolerance (needing more to achieve the same effect) and psychological craving. Dependence and misuse are primarily documented in chronic, unsupervised recreational use patterns involving frequent, high-dose consumption over extended periods.¹⁰

The dosing patterns, frequency, and context of therapeutic ketamine programs differ substantially from recreational use. The intake process evaluates each individual's substance use history before sessions begin.

Defined session frequency, physician-determined dosing, and ongoing monitoring are designed to minimize misuse risk as a proactive element of care design.

How Care Protocols Support Safer Ketamine Therapy and More Durable Outcomes

A care protocol is the defined set of procedures—screening, dosing, monitoring, and follow-up—that governs how ketamine therapy is delivered. The quality and rigor of these protocols directly influence both safety and therapeutic outcomes.

The therapeutic value of ketamine is not solely in the molecule, but in how the molecule is delivered within a care framework. Screening determines eligibility, provider oversight ensures appropriate dosing, and integration translates neuroplastic changes into lasting behavioral shifts. When evaluating any ketamine program, the rigor of this framework matters as much as the medication itself.

What Does Medical Screening for Ketamine Therapy Include?

A licensed provider evaluates each individual's diagnosis, history, and goals to determine whether ketamine is appropriate. A thorough screening process includes a comprehensive health history review, psychiatric evaluation, medication interaction assessment, and cardiovascular evaluation. It also involves reviewing substance use history and aligning on treatment goals.

The evaluation determines not just eligibility but also informs the provider's approach to dosing and session structure. Proper screening ensures each individual receives care appropriate for their specific situation.

What Monitoring and Support Should Be in Place During Ketamine Therapy?

In-session and ongoing monitoring elements include vital sign tracking, such as blood pressure and heart rate. A peer treatment monitor is required to be present during every session to ensure physical safety.

Care team availability for questions or concerns and protocols for managing unexpected reactions are also standard. Monitoring provides the safety foundation that allows individuals to engage more fully with the therapeutic experience.

What Preparation and Integration Practices Can Support More Durable Outcomes?

Preparation involves intention-setting, understanding what to expect, and environmental setup. Integration involves reflection, journaling, coaching, and group discussion to extend the benefits of each session beyond the acute pharmacological window.

Integration is the practice of using the neuroplastic window deliberately. While self-directed practices like journaling are valuable, guided integration support adds an additional layer of accountability and insight.

What Does Mindbloom's Supervised at-Home Ketamine Therapy Include?

Building on decades of peer-reviewed research on ketamine's therapeutic applications, Mindbloom has published two of the largest published, real-world outcomes studies of at-home ketamine therapy to date in the Journal of Affective Disorders (Hull et al., 2022; Mathai et al., 2024).^1,2 The studies were conducted on Mindbloom clients using the Mindbloom care protocol.

Mindbloom's care model includes:

• Clinician consults: Licensed prescribers evaluate eligibility, prescribe treatment, and monitor progress.
• Defined programs: 6, 12, or 18 sessions personalized based on medical needs and goals.
• Guide coaching: 1:1 coaching sessions for preparation and integration support.
• Peer treatment monitor: Required to be present during every session as part of the safety protocol.
• Group Integration Circles: Unlimited access to facilitated group sessions for shared reflection and community support.
• Administration options: Both sublingual tablets and subcutaneous injectables are available. Mindbloom is the only at-home ketamine provider offering subcutaneous administration, enabling more consistent dosing and bioavailability.
• Bloombox: An experiential toolkit with all session essentials, designed to optimize set and setting.
• Mindbloom App: Comprehensive app-guided programs with original soundscapes composed by an in-house composer and music therapist, preparation, and integration resources.

Mindbloom's at-home ketamine therapy starts at $165 per session for an 18-session program for new clients. Returning clients pay as little as $129 per session with an 18-session program.

In a Mindbloom peer-reviewed study of 11,441 clients, 89% reported improvement in their depression and anxiety symptoms.²

Mindbloom's at-home model is approximately 60% more affordable per session than IV ketamine clinics, and published outcomes show symptom improvement rates comparable to those reported in IV ketamine studies, although cross-study comparisons should be interpreted cautiously because study designs, patient populations, and outcome measures differ.⁸

Explore whether ketamine therapy may be right for you — Book My Breakthrough.

Important Safety Information

Ketamine is not FDA-approved for PTSD, depression, or anxiety. Common side effects include dissociation, increased blood pressure, nausea, dizziness, and cognitive impairment. Ketamine has abuse potential and is not appropriate for patients with uncontrolled hypertension, psychotic disorders, or substance use disorders. Do not drive or operate machinery until the day after treatment. Individual results may vary. Full safety information: www.mindbloom.com/safety-information

Off-Label Use Disclosure

Ketamine is FDA-approved only as an anesthetic. Use for mental health conditions represents off-label prescribing by licensed clinicians based on clinical judgment. Schedule III Controlled Substance - DEA regulations apply.